I agree he would be a great benefit but prefer to see OZNT keep his unofficial arms length role on our side of the fence.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025